Matches in Wikidata for { <http://www.wikidata.org/entity/Q84066452> ?p ?o ?g. }
- Q84066452 description "2011 nî lūn-bûn" @default.
- Q84066452 description "2011年の論文" @default.
- Q84066452 description "2011年学术文章" @default.
- Q84066452 description "2011年学术文章" @default.
- Q84066452 description "2011年学术文章" @default.
- Q84066452 description "2011年学术文章" @default.
- Q84066452 description "2011年学术文章" @default.
- Q84066452 description "2011年学术文章" @default.
- Q84066452 description "2011年學術文章" @default.
- Q84066452 description "2011年學術文章" @default.
- Q84066452 description "2011年學術文章" @default.
- Q84066452 description "2011年學術文章" @default.
- Q84066452 description "2011年學術文章" @default.
- Q84066452 description "2011년 논문" @default.
- Q84066452 description "article científic" @default.
- Q84066452 description "article scientific" @default.
- Q84066452 description "article scientifique" @default.
- Q84066452 description "articol științific" @default.
- Q84066452 description "articolo scientifico" @default.
- Q84066452 description "artigo científico" @default.
- Q84066452 description "artigo científico" @default.
- Q84066452 description "artigo científico" @default.
- Q84066452 description "artikel ilmiah" @default.
- Q84066452 description "artikull shkencor" @default.
- Q84066452 description "artikulong pang-agham" @default.
- Q84066452 description "artykuł naukowy" @default.
- Q84066452 description "artículo científico publicado en 2011" @default.
- Q84066452 description "artículu científicu" @default.
- Q84066452 description "bilimsel makale" @default.
- Q84066452 description "bài báo khoa học" @default.
- Q84066452 description "naučni članak" @default.
- Q84066452 description "scienca artikolo" @default.
- Q84066452 description "scientific article published on 07 May 2011" @default.
- Q84066452 description "scientific article published on 7 May 2011" @default.
- Q84066452 description "scientific article published on 7 May 2011" @default.
- Q84066452 description "teaduslik artikkel" @default.
- Q84066452 description "tieteellinen artikkeli" @default.
- Q84066452 description "tudományos cikk" @default.
- Q84066452 description "vedecký článok" @default.
- Q84066452 description "vetenskaplig artikel" @default.
- Q84066452 description "videnskabelig artikel udgivet 7. maj 2011" @default.
- Q84066452 description "vitenskapelig artikkel" @default.
- Q84066452 description "vitskapeleg artikkel" @default.
- Q84066452 description "vědecký článek" @default.
- Q84066452 description "wetenschappelijk artikel" @default.
- Q84066452 description "wissenschaftlicher Artikel" @default.
- Q84066452 description "επιστημονικό άρθρο" @default.
- Q84066452 description "мақолаи илмӣ" @default.
- Q84066452 description "наукова стаття, опублікована в травні 2011" @default.
- Q84066452 description "научна статия" @default.
- Q84066452 description "научная статья" @default.
- Q84066452 description "научни чланак" @default.
- Q84066452 description "научни чланак" @default.
- Q84066452 description "מאמר מדעי" @default.
- Q84066452 description "مقالة علمية نشرت في 7 مايو 2011" @default.
- Q84066452 description "৭ মে ২০১১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q84066452 description "บทความทางวิทยาศาสตร์" @default.
- Q84066452 description "სამეცნიერო სტატია" @default.
- Q84066452 name "Treatment of myelodysplastic syndromes with excess of blasts by bevacizumab is well tolerated and is associated with a decrease of VEGF plasma level" @default.
- Q84066452 name "Treatment of myelodysplastic syndromes with excess of blasts by bevacizumab is well tolerated and is associated with a decrease of VEGF plasma level" @default.
- Q84066452 type Item @default.
- Q84066452 label "Treatment of myelodysplastic syndromes with excess of blasts by bevacizumab is well tolerated and is associated with a decrease of VEGF plasma level" @default.
- Q84066452 label "Treatment of myelodysplastic syndromes with excess of blasts by bevacizumab is well tolerated and is associated with a decrease of VEGF plasma level" @default.
- Q84066452 prefLabel "Treatment of myelodysplastic syndromes with excess of blasts by bevacizumab is well tolerated and is associated with a decrease of VEGF plasma level" @default.
- Q84066452 prefLabel "Treatment of myelodysplastic syndromes with excess of blasts by bevacizumab is well tolerated and is associated with a decrease of VEGF plasma level" @default.
- Q84066452 P1433 Q84066452-969F57AB-C671-4475-BEB6-F4C72392E18D @default.
- Q84066452 P1476 Q84066452-9E8BE841-A426-42E5-865B-17A961794F21 @default.
- Q84066452 P2093 Q84066452-12B2092B-FDC8-4C2D-A398-A7A6F7A0DFCC @default.
- Q84066452 P2093 Q84066452-26B90FDE-4BD0-46EE-B0FC-67FE7F31ADF2 @default.
- Q84066452 P2093 Q84066452-716FF24A-4835-42B8-B956-234C326DE496 @default.
- Q84066452 P2093 Q84066452-7BF194BF-645F-43B4-8B48-CE1A1269630B @default.
- Q84066452 P2093 Q84066452-8CBB5AEF-E2AD-4D3A-83C6-7F0825E8A1F9 @default.
- Q84066452 P2093 Q84066452-92D4083F-0437-4A3C-8C25-0007C9146EF8 @default.
- Q84066452 P2093 Q84066452-A75F8721-79AD-48F2-AEA8-A8035BC4C917 @default.
- Q84066452 P2093 Q84066452-B6629E83-3E2C-4CDC-83D9-AAC387656D67 @default.
- Q84066452 P2093 Q84066452-B7F4FC46-3316-423D-BAD3-4954DB49C0A5 @default.
- Q84066452 P2093 Q84066452-BF4B371F-D8D2-44AC-87DF-AF1B27DA8969 @default.
- Q84066452 P2093 Q84066452-BFCFA306-B0AF-46CC-98B9-6F9675911980 @default.
- Q84066452 P2093 Q84066452-C5B1EC86-2D89-4C0B-BCFE-A50B96C9FB37 @default.
- Q84066452 P2093 Q84066452-CAF0BF66-C671-40E5-A22B-7F528660E0BF @default.
- Q84066452 P2093 Q84066452-EF2AAE48-B8BC-48A5-BF30-98D42FE4AE82 @default.
- Q84066452 P2093 Q84066452-EF3ED663-3891-4DB8-BA07-CE58F44FC0A5 @default.
- Q84066452 P2093 Q84066452-FD53C3CD-0EE3-4174-9B8A-E12FCE1CE69A @default.
- Q84066452 P304 Q84066452-892C6C23-BA03-4A3A-9E5B-CDA47D78F703 @default.
- Q84066452 P31 Q84066452-C81601AC-977A-473A-A64C-1E40565D3BC1 @default.
- Q84066452 P356 Q84066452-577D4978-B4B4-4F40-BE64-ED105D9534BC @default.
- Q84066452 P433 Q84066452-96961737-6E57-4591-B5C1-A5AB47BCC4D7 @default.
- Q84066452 P478 Q84066452-E3C54D7C-4268-48E2-BE03-5F0FD19F0B62 @default.
- Q84066452 P50 Q84066452-30EAFA5C-34AE-4327-BDF5-70ECD79D198D @default.
- Q84066452 P50 Q84066452-CEA7BC36-EDB6-4DF6-ACC7-CE8D614C2ECB @default.
- Q84066452 P577 Q84066452-592437F9-59FA-4640-97FE-DDC3E0061AF2 @default.
- Q84066452 P698 Q84066452-47DFB60A-3092-41C2-8464-93AF8B92D260 @default.
- Q84066452 P921 Q84066452-EC215790-5394-4E69-858F-06A6F0E05DBC @default.
- Q84066452 P356 S00277-011-1242-Z @default.
- Q84066452 P698 21553011 @default.
- Q84066452 P1433 Q15766509 @default.
- Q84066452 P1476 "Treatment of myelodysplastic syndromes with excess of blasts by bevacizumab is well tolerated and is associated with a decrease of VEGF plasma level" @default.
- Q84066452 P2093 "Anne-Odile Hueber" @default.
- Q84066452 P2093 "Bohrane Slama" @default.
- Q84066452 P2093 "Bruno Richard" @default.